Aristotle University Of Thessaloniki (AUTH)
Συμβολή της μεταβολομικής ανάλυσης γαστρικού υγρού, ούρων και αμνιακού υγρού προώρων νεογνών στην πρώιμη πρόβλεψη επιπλοκών της προωρότητας
Abstract
dc:descriptionPrematurity and associated respiratory conditions, particularly respiratory distress syndrome (RDS), are the most common reasons for the hospitalization of preterm neonates in neonatal intensive care units and are the leading cause of early neonatal morbidity and mortality. The prediction of survival and the development of RDS requiring the administration of exogenous surfactant (SF) in very preterm neonates is crucial for everyday clinical practice and parental counseling. The use of advanced bioanalytical approaches, such as metabolomics, may play a key role in identifying biomarkers that enable the early prediction of significant medical issues, such as RDS, and the likelihood of survival. In this context, two prospective studies were conducted in very premature newborns (< 32 weeks of gestation) as part of this PhD thesis. The first study, involving 96 neonates, assessed the role of untargeted metabolomic analysis of gastric fluid and urine using gas chromatography-mass spectrometry (GC-MS) obtained soon after birth in predicting survival at days 3 and 15 of life (DOL), as well as overall survival until discharge from the hospital. The second study, a case-control study, involved 43 neonates with RDS who received exogenous SF (patients) and 30 neonates with mild or no RDS (controls) who did not require SF. It evaluated whether targeted gastric fluid metabolomic analysis (GC-MS), obtained in the first hour of life, could predict the need for SF replacement therapy in RDS. Demographic, perinatal, and neonatal characteristics were recorded, and both univariate and multivariate statistical analyses were performed to identify significant metabolites and assess their prognostic value. The study on the prognosis of survival identified differences in various metabolites between survivors and non-survivors at the specified study time points. Binary logistic regression showed that certain metabolites in the gastric fluid including arabitol as well as succinic, erythronic and threonic acids were associated with DOL 15 and overall survival. Gastric glyceric acid was also associated with DOL 15 survival. Urine glyceric acid could predict survival on DOL 3 and overall survival. In the case-control study on predicting the need for exogenous SF using non-targeted analysis of gastric fluid (GC-MS), the analysis revealed significant differences between the two groups in gastric fluid metabolites (L-glycine and acetyl-L-serine) and clinical parameters (gestational age, 1- and 5-minute Apgar scores, and intubation in the delivery room). Moreover, multivariate analysis identified intubation in the delivery room as the strongest clinical predictor of SF administration [AUC 0.69 (95% CI 0.57-0.81)]. The combination of metabolomic and clinical data enabled the construction of a model with good accuracy [AUC 0.76 (95% CI 0.64-0.86)] in predicting the need for SF replacement therapy. In conclusion, non-surviving preterm neonates exhibit a different metabolic profile compared to survivors, enabling their differentiation through GC-MS-based metabolomic analysis of gastric fluid and urine. The results of this study support the use of metabolomics in developing survival biomarkers for very preterm infants. In contrast, gastric fluid metabolite profiling alone was insufficient to predict which preterm neonates with RDS would require exogenous SF as rescue therapy. However, the integration of metabolic and clinical data improved the accuracy of predicting the need for exogenous SF. Despite the encouraging results of the two studies, further research is necessary to explore the role of metabolomic analysis of gastric fluid in predicting important medical conditions and outcomes in very preterm infants. With the future development of diagnostic tests that are easily applicable in the NICU setting, metabolomics holds the potential for significant advancements in the optimal and individualized management of sick neonates.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Besiri, Konstantia
- Μπεσίρη, Κωνσταντία
Subjects
dc:subject × 22- Γαστρικό υγρό
- Σύνδρομο Αναπνευστικής Δυσχέρειας (ΣΑΔ)
- Αέρια χρωματογραφία-Φασματομετρία μάζας
- Προωρότητα
- Επιφανειοδραστικός παραγόντας
- Πρόβλεψη
- Επιβίωση
- Ούρα
- Gastric fluid
- Respiratory Distress Syndrome (RDS)
- Gas Chromatography–Mass Spectrometry (GC-MS)
- Prematurity
- Surfactant
- Prediction
- Survival
- Urine
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Παιδιατρική, Νεογνολογία και Υγεία του παιδιού
- Clinical Medicine
- Medical and Health Sciences
- Pediatrics, Perinatology and Child Health
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58028